ECM Therapeutics, Inc.
Paul Fagan has a solid work experience in various roles and companies. Paul is currently serving as the Chief Executive Officer at ECM Therapeutics, Inc. since April 2018. Before that, they worked at Three Rivers Pharmaceuticals, LLC from April 2000 to October 2010, where they held the positions of Co-Founder, Executive Vice President, and General Counsel. Prior to that, Paul was an Attorney at Tucker Arensberg, P.C. from October 1990 to November 2000. Paul started their career as a Certified Public Accountant at EY in December 1986 and worked there until September 1990.
Paul Fagan has a Bachelor of Science degree in Accounting from Indiana University of Pennsylvania. Paul also obtained a Juris Doctor degree from the Thomas R. Kline School of Law of Duquesne University. In addition, they hold a Master of Business Administration from the MIT Sloan School of Management.
This person is not in any teams
ECM Therapeutics, Inc.
1 followers
ECM Therapeutics is a regenerative medicine company that develops natural biomaterial to treat disease and injury. The company also develops and manufactures diagnostic and therapeutic products derived from a naturally occurring material called extracellular matrix (ECM). It provides cues for cell attachment, migration, proliferation, and 3-Dspatial organization.ECM Therapeutics' patented ECM hydrogel technology allows for expanded, less invasive applications in multiple disease areas. It utilizes the body’s own template to restore naturally occurring functional tissue following injury.ECM Therapeutics was founded in 2018 and is based in Warrendale, Pennsylvania, United States.